Wesana Health Announces Closing of Previously Announced SANA-013 Asset Sale
05 juil. 2023 07h30 HE
|
Wesana Health
CHICAGO and TORONTO, July 05, 2023 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE:WESA; OTCQB:WSNAF), today announced the successful closing of the sale by Wesana...
Wesana Health Announces Voting Results of AGSM
09 juin 2023 16h48 HE
|
Wesana Health
CHICAGO and TORONTO, June 09, 2023 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), today announced that all matters put forward at the...
Wesana Health Announces Sale of SANA-13 Assets to Lucy Scientific Discovery
21 mars 2023 09h00 HE
|
Wesana Health
CHICAGO and TORONTO, March 21, 2023 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data-driven life sciences company, today announced that...
Wesana Health Announces Receipt of Short-Term Loan
16 déc. 2022 17h00 HE
|
Wesana Health
CHICAGO and TORONTO, Dec. 16, 2022 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data-driven life sciences company, today announced that...
Wesana Announces Sale of Clinic Management Services Organization
01 sept. 2022 19h15 HE
|
Wesana Health
CHICAGO and TORONTO, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data-driven life sciences company focused on developing...
Wesana Announces Second Quarter 2022 Financial Results
29 août 2022 20h00 HE
|
Wesana Health
CHICAGO and TORONTO, Aug. 29, 2022 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data-driven life sciences company focused on developing...
Wesana Health CEO Daniel Carcillo to Keynote Charles River Symposium: Re-Imagining Substance Abuse, Addiction, and Mental Health Disorders with Psychedelic Therapies
08 juin 2022 09h46 HE
|
Wesana Health
CHICAGO and TORONTO, June 08, 2022 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data-driven life sciences company focused on developing...
Wesana Announces First Quarter 2022 Financial Results
31 mai 2022 17h30 HE
|
Wesana Health
CHICAGO and TORONTO, May 31, 2022 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data-driven life sciences company focused on developing the...
Wesana Health Outlines Accelerated Drug Development Pathway
10 mai 2022 07h30 HE
|
Wesana Health
CHICAGO and TORONTO, May 10, 2022 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data-driven life sciences company focused on developing the...
Wesana Announces Singular Focus on Drug Development Prompting a Strategic Review of its Clinics and Other Care Delivery Assets
05 mai 2022 09h09 HE
|
Wesana Health
CHICAGO and TORONTO, May 05, 2022 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data-driven life sciences company focused on developing the...